Figure 7.
NM II is required for mitotic spindle formation in HL-1 cells. (A) Immunoblot analysis of NMHC II isoform expression in HL-1 cells. All three isoforms of NMHC II are detected in HL-1 cells. RBL cells and COS-7 cells are used as positive controls for NMHC II-A or NMHC II-B and II-C, respectively. Actin is a loading control. (B) Immunoblot analysis shows double knockdown of NMHC II-A and II-B 72 h after siRNA II-A and II-B treatment. (C) Immunofluorescence confocal images show typical metaphase mitotic spindles (red, β-tubulin; blue, DAPI staining) from control (a), 72 h after NMHC II-A and II-B double siRNA treatment (b and c), and 4 h after 50 μM blebbistatin treatment (d) of HL-1 cells. Simultaneous siRNA NM II-A and II-B knockdown or blebbistatin-treated HL-1 cells develop abnormal spindles. (D) Quantification of abnormal mitotic spindles in HL-1 cells after 72 h of siRNA NMHC II knockdown or 4 h of blebbistatin treatment. Note that simultaneous siRNA knockdown of NM II-A and II-B markedly increases the percentage of HL-1 cells showing abnormal spindles compared with siRNA NM II-A or II-B knockdown alone. (E) Immunofluorescence confocal images of the mitotic spindle from control HL-1 cells stained for NMHC II-A (a and c, green) II-B (b and d, green), and β-tubulin (a and b, red). NMHC II-A and II-B costain with β-tubulin (top, yellow), indicating localization of both NMHC II-A and II-B in mitotic spindles of dividing HL-1 cells, in addition to their cortical localizations (green).